Research ArticleArticle
Evaluation of the Implementation of Guidelines on the Treatment of Osteoporosis in Patients with Rheumatoid Arthritis
Sandrine Malochet-Guinamand, Céline Lambert, Laure Gossec, Martin Soubrier and Maxime Dougados
The Journal of Rheumatology March 2019, jrheum.180889; DOI: https://doi.org/10.3899/jrheum.180889
Sandrine Malochet-Guinamand
From the Rheumatology Department, and Biostatistics Unit (DRCI), University Hospital Clermont-Ferrand, Auvergne; Sorbonne University; Pitié Salpêtrière Hospital, AP-HP, Rheumatology Department; Rheumatology Department, Cochin Hospital, AP-HP, Paris Descartes University; Clinical Epidemiology and Biostatistics, INSERM (U1153), PRES Sorbonne Paris-Cité, Paris, France. S. Malochet-Guinamand, MD, University Hospital Clermont-Ferrand, Rheumatology Department; C. Lambert, MSc, University Hospital Clermont-Ferrand, Biostatistics Unit (DRCI); L. Gossec, PhD, Sorbonne University, and Pitié Salpêtrière Hospital, AP-HP, Rheumatology Department; M. Soubrier, PhD, University Hospital Clermont-Ferrand, Rheumatology Department; M. Dougados, PhD, Rheumatology Department, Cochin Hospital, AP-HP, Paris Descartes University, and Clinical Epidemiology and Biostatistics, INSERM (U1153), PRES Sorbonne Paris-Cité. Address correspondence to Dr. S. Malochet-Guinamand, Clermont-Ferrand University Hospital, Rheumatology Department, 58 Rue Montalembert, Clermont-Ferrand, 63003 France. E-mail: smalochet@chu-clermontferrand.fr. Accepted for publication February 28, 2019.
Céline Lambert
From the Rheumatology Department, and Biostatistics Unit (DRCI), University Hospital Clermont-Ferrand, Auvergne; Sorbonne University; Pitié Salpêtrière Hospital, AP-HP, Rheumatology Department; Rheumatology Department, Cochin Hospital, AP-HP, Paris Descartes University; Clinical Epidemiology and Biostatistics, INSERM (U1153), PRES Sorbonne Paris-Cité, Paris, France. S. Malochet-Guinamand, MD, University Hospital Clermont-Ferrand, Rheumatology Department; C. Lambert, MSc, University Hospital Clermont-Ferrand, Biostatistics Unit (DRCI); L. Gossec, PhD, Sorbonne University, and Pitié Salpêtrière Hospital, AP-HP, Rheumatology Department; M. Soubrier, PhD, University Hospital Clermont-Ferrand, Rheumatology Department; M. Dougados, PhD, Rheumatology Department, Cochin Hospital, AP-HP, Paris Descartes University, and Clinical Epidemiology and Biostatistics, INSERM (U1153), PRES Sorbonne Paris-Cité. Address correspondence to Dr. S. Malochet-Guinamand, Clermont-Ferrand University Hospital, Rheumatology Department, 58 Rue Montalembert, Clermont-Ferrand, 63003 France. E-mail: smalochet@chu-clermontferrand.fr. Accepted for publication February 28, 2019.
Laure Gossec
From the Rheumatology Department, and Biostatistics Unit (DRCI), University Hospital Clermont-Ferrand, Auvergne; Sorbonne University; Pitié Salpêtrière Hospital, AP-HP, Rheumatology Department; Rheumatology Department, Cochin Hospital, AP-HP, Paris Descartes University; Clinical Epidemiology and Biostatistics, INSERM (U1153), PRES Sorbonne Paris-Cité, Paris, France. S. Malochet-Guinamand, MD, University Hospital Clermont-Ferrand, Rheumatology Department; C. Lambert, MSc, University Hospital Clermont-Ferrand, Biostatistics Unit (DRCI); L. Gossec, PhD, Sorbonne University, and Pitié Salpêtrière Hospital, AP-HP, Rheumatology Department; M. Soubrier, PhD, University Hospital Clermont-Ferrand, Rheumatology Department; M. Dougados, PhD, Rheumatology Department, Cochin Hospital, AP-HP, Paris Descartes University, and Clinical Epidemiology and Biostatistics, INSERM (U1153), PRES Sorbonne Paris-Cité. Address correspondence to Dr. S. Malochet-Guinamand, Clermont-Ferrand University Hospital, Rheumatology Department, 58 Rue Montalembert, Clermont-Ferrand, 63003 France. E-mail: smalochet@chu-clermontferrand.fr. Accepted for publication February 28, 2019.
Martin Soubrier
From the Rheumatology Department, and Biostatistics Unit (DRCI), University Hospital Clermont-Ferrand, Auvergne; Sorbonne University; Pitié Salpêtrière Hospital, AP-HP, Rheumatology Department; Rheumatology Department, Cochin Hospital, AP-HP, Paris Descartes University; Clinical Epidemiology and Biostatistics, INSERM (U1153), PRES Sorbonne Paris-Cité, Paris, France. S. Malochet-Guinamand, MD, University Hospital Clermont-Ferrand, Rheumatology Department; C. Lambert, MSc, University Hospital Clermont-Ferrand, Biostatistics Unit (DRCI); L. Gossec, PhD, Sorbonne University, and Pitié Salpêtrière Hospital, AP-HP, Rheumatology Department; M. Soubrier, PhD, University Hospital Clermont-Ferrand, Rheumatology Department; M. Dougados, PhD, Rheumatology Department, Cochin Hospital, AP-HP, Paris Descartes University, and Clinical Epidemiology and Biostatistics, INSERM (U1153), PRES Sorbonne Paris-Cité. Address correspondence to Dr. S. Malochet-Guinamand, Clermont-Ferrand University Hospital, Rheumatology Department, 58 Rue Montalembert, Clermont-Ferrand, 63003 France. E-mail: smalochet@chu-clermontferrand.fr. Accepted for publication February 28, 2019.
Maxime Dougados
From the Rheumatology Department, and Biostatistics Unit (DRCI), University Hospital Clermont-Ferrand, Auvergne; Sorbonne University; Pitié Salpêtrière Hospital, AP-HP, Rheumatology Department; Rheumatology Department, Cochin Hospital, AP-HP, Paris Descartes University; Clinical Epidemiology and Biostatistics, INSERM (U1153), PRES Sorbonne Paris-Cité, Paris, France. S. Malochet-Guinamand, MD, University Hospital Clermont-Ferrand, Rheumatology Department; C. Lambert, MSc, University Hospital Clermont-Ferrand, Biostatistics Unit (DRCI); L. Gossec, PhD, Sorbonne University, and Pitié Salpêtrière Hospital, AP-HP, Rheumatology Department; M. Soubrier, PhD, University Hospital Clermont-Ferrand, Rheumatology Department; M. Dougados, PhD, Rheumatology Department, Cochin Hospital, AP-HP, Paris Descartes University, and Clinical Epidemiology and Biostatistics, INSERM (U1153), PRES Sorbonne Paris-Cité. Address correspondence to Dr. S. Malochet-Guinamand, Clermont-Ferrand University Hospital, Rheumatology Department, 58 Rue Montalembert, Clermont-Ferrand, 63003 France. E-mail: smalochet@chu-clermontferrand.fr. Accepted for publication February 28, 2019.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Evaluation of the Implementation of Guidelines on the Treatment of Osteoporosis in Patients with Rheumatoid Arthritis
Sandrine Malochet-Guinamand, Céline Lambert, Laure Gossec, Martin Soubrier, Maxime Dougados
The Journal of Rheumatology Mar 2019, jrheum.180889; DOI: 10.3899/jrheum.180889